[Redding California], [20-11-2023] – Meticulous Research, a renowned market research company, has conducted an in-depth analysis of the Tissue Diagnostics Market, unveiling the top 10 companies driving the industry. The market is anticipated to reach $8.52 billion by 2029, growing at a CAGR of 7.4% from 2022 to 2029.
Tissue diagnostics plays a pivotal role in disease diagnosis, especially in cancer, utilizing advanced instruments such as slide staining systems, slide scanners, tissue processing systems, embedding systems, and tissue microarrays. This crucial study is conducted in hospitals, reference laboratories, research institutes, pharmaceutical companies, and contract research organizations.
The growth of the Tissue Diagnostics Market is primarily attributed to the global increase in cancer prevalence, the availability of biomarkers for cancer diagnosis and therapy, cancer screening programs, a surge in clinical trials for cancer drugs, advanced tissue-based companion diagnostic tests, and the growing global geriatric population. Additionally, the rising focus on personalized healthcare, adoption of digital pathology, automation in tissue diagnostics, and opportunities in emerging economies contribute significantly to market expansion.
Here are the top 10 companies operating in the Tissue Diagnostics Market: https://meticulousblog.org/top-10-companies-in-tissue-diagnostics-market/
F. Hoffmann-La Roche Ltd. (Switzerland):
Founded in 1896, F. Hoffmann-La Roche Ltd. is a research-based healthcare company providing innovative medicines and diagnostic solutions. The company operates globally through Pharmaceuticals and Diagnostics segments.
Thermo Fisher Scientific Inc. (U.S.):
Established in 2006, Thermo Fisher Scientific Inc. is a biotechnology company specializing in life sciences research, patient diagnostics, and laboratory productivity. The company offers diagnostic test kits, reagents, instruments, and associated products.
Abbott Laboratories (U.S.):
Founded in 1888, Abbott Laboratories is a global healthcare company operating in diagnostics, medical devices, nutrition, and branded generic pharmaceuticals markets. Abbott's Diagnostic segment offers tissue diagnostics products through Molecular Diagnostics subsegment.
Danaher Corporation (U.S.):
Founded in 1969, Danaher Corporation designs, manufactures, and markets medical, professional, industrial, and commercial products. The company offers a range of products in the tissue diagnostics market through its Diagnostics segment.
QIAGEN N.V. (Netherlands):
Established in 1984, QIAGEN N.V. is engaged in the development and sales of instruments, consumables, and digital bioinformatics solutions for various diagnostic applications. The company operates through Molecular Diagnostics and Life Sciences segments.
Becton, Dickinson and Company (U.S.):
Founded in 1897, BD is a medical technology company manufacturing and selling a wide range of medical devices, laboratory equipment, and diagnostic products. The BD Life Sciences segment operates in the tissue diagnostics market through the Biosciences category.
Abcam plc (U.K.):
Established in 1998, Abcam plc is involved in the identification, development, and distribution of high-quality biological reagents and tools used in scientific research, diagnostics, and drug discovery.
Agilent Technologies (U.S.):
Incorporated in 1999, Agilent Technologies provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets. The company offers tissue diagnostics through its Diagnostics and Genomics segment.
Merck KGaA (Germany):
Founded in 1668, Merck is a science and technology company operating through Healthcare, Life Sciences, and Electronics segments. The Life Sciences segment offers a diverse range of products in the tissue diagnostics market.
Sakura Finetek Japan Co., Ltd. (Japan):
Established in 2001, Sakura Finetek Japan is a healthcare-based pathology automation company specializing in cancer diagnosis. The company engages in the R&D, manufacture, sales, and export/import of medical specimen preparation instruments, consumables, reagents, and related products.
Top 10 Companies Leading the Tissue Diagnostics Revolution: https://meticulousblog.org/top-10-companies-in-tissue-diagnostics-market/
Meticulous Research's latest report on the Tissue Diagnostics Market predicts a growth rate of 7.4% during the forecast period of 2022-2029.
For more detailed information on the financial performance, key products, company strategies, partnerships, and acquisitions of these companies, refer to Meticulous Research®'s latest report, "Tissue Diagnostics Market – Global Opportunity Analysis and Industry Forecast (2022-2029)."
The comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends in the Tissue Diagnostics Market.
For media inquiries or more information, please contact:
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research